Locus Biosciences, which is using new gene editing technology to create drugs that destroy antibiotic-resistance bacteria, has raised $19 million. Artis Ventures led the round, joined by Tencent Holdings Ltd., Abstract Ventures and others. Locus, based in Morrisville, got its start with loans from the North Carolina Biotechnology Center.
RALEIGH, N.C. (WNCN) — The lull in tropical activity only lasted a few days it seems as we could be on the verge of another named tropical system by the end of the week. CLICK IMAGE TO ENLARGE After having an incredibly busy September with storms like Maria, Lee, Jose, Katia and Maria, October started […]
International initiative affords defensive end Efe Obada the opportunity to spend the season with Panthers, honing his skills in a sport he’s only been playing for three years.
With defensive line coach Eric Washington’s guidance, third-round draft choice off to a fast start in his effort to get up to speed.